TNSN96021A1 - Indoles substitues - Google Patents

Indoles substitues

Info

Publication number
TNSN96021A1
TNSN96021A1 TNTNSN96021A TNSN96021A TNSN96021A1 TN SN96021 A1 TNSN96021 A1 TN SN96021A1 TN TNSN96021 A TNTNSN96021 A TN TNSN96021A TN SN96021 A TNSN96021 A TN SN96021A TN SN96021 A1 TNSN96021 A1 TN SN96021A1
Authority
TN
Tunisia
Prior art keywords
substituted indoles
medicinal products
appropriate
indoles
substituted
Prior art date
Application number
TNTNSN96021A
Other languages
English (en)
Inventor
Matthias Muller-Gliemann Dr
Ulrich Muller Dr
Martin Beuck Dr
Siegfried Zaiss Dr
Christoph Gerdes Dr
Anke Domdey-Bette Dr
Rudi Grutzmann Dr
Stefan Lohmer Dr
Stefan Wohlfeil Dr
Ozkan Yalkinoglu Dr
James Elting Dr
Dirk Denzer Dr
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of TNSN96021A1 publication Critical patent/TNSN96021A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ON PREPARE DES INDOLES SUBSTITUES EN FAISANT REAGIR AVEC DES AMINES APPROPRIEES DES ACIDES CARBOXYLIQUES APPROPRIES, EVENTUELLEMENT EN PRESENCE DE SUBSTANCES AUXILIAIRES. LES INDOLES SUBSTITUES CONVIENNENT COMME PRINCIPES ACTIFS DANS DES MEDICAMENTS, EN PARTICULIER DANS LES MEDICAMENTS DESTINES AU TRAITEMENT DE L'ARTERIOSCLEROSE ET DE LA RESTENOSE
TNTNSN96021A 1995-02-01 1996-02-01 Indoles substitues TNSN96021A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19503159 1995-02-01
DE19513716A DE19513716A1 (de) 1995-02-01 1995-04-11 Substituierte 2-Phenylindol-Derivate

Publications (1)

Publication Number Publication Date
TNSN96021A1 true TNSN96021A1 (fr) 2005-03-15

Family

ID=7752848

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN96021A TNSN96021A1 (fr) 1995-02-01 1996-02-01 Indoles substitues

Country Status (10)

Country Link
KR (1) KR960031439A (fr)
DE (2) DE19513716A1 (fr)
MY (1) MY132270A (fr)
RU (1) RU2162842C2 (fr)
SG (1) SG38925A1 (fr)
SV (1) SV1996000009A (fr)
TN (1) TNSN96021A1 (fr)
TW (1) TW349092B (fr)
YU (1) YU5796A (fr)
ZA (1) ZA96726B (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2517659A1 (de) * 1975-04-22 1976-11-11 Merck Patent Gmbh Indolderivate und verfahren zu ihrer herstellung
DE3739882A1 (de) * 1987-11-25 1989-06-08 Bayer Ag Substituierte hydroxylamine
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides

Also Published As

Publication number Publication date
RU2162842C2 (ru) 2001-02-10
SG38925A1 (en) 1997-04-17
KR960031439A (ko) 1996-09-17
DE59605373D1 (de) 2000-07-13
ZA96726B (en) 1996-08-20
SV1996000009A (es) 1996-11-14
MY132270A (en) 2007-09-28
DE19513716A1 (de) 1996-08-08
YU5796A (sh) 1999-03-04
TW349092B (en) 1999-01-01

Similar Documents

Publication Publication Date Title
TNSN97048A1 (fr) Pyridines 2 - aryl - substituees.
TNSN96035A1 (fr) Derives de n-(3-benzofurannyl) uree
DE69737719D1 (de) Substituierte gamma-aminobuttersäurederivate als arzneimittel
CA2217515A1 (fr) Composition pharmaceutique contenant des inhibiteurs de pompe a protons
DE69331739D1 (de) Neuartige pharmazeutische verwendungen von krill-enzymen
ATE215373T1 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
MX9602973A (es) Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida.
TNSN96005A1 (en) 2-(2-n-alcoxyphenyl)-purine-6-ones 9-substituees
DK0562705T3 (da) Anvendelse af L-deprenyl til fremstilling af et lægemiddel til behandling af Cushings sygdom
DE69632396D1 (de) Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
DE59610175D1 (de) Hydantoinderivate als zwischenprodukte für pharmazeutische wirkstoffe
TNSN96016A1 (fr) Utilisation de phenylcyclohexylcarboxamides
IT1276162B1 (it) Geranilgeranil-derivati,procedimento per la loro preparazione e relative composizioni farmaceutiche
BG105275A (en) Tan-1057 derivatives
DE69612056T2 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
TNSN96021A1 (fr) Indoles substitues
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
ATE181324T1 (de) Im kardiovaskulären system aktive seco-d-steroide und diese enthaltende pharmazeutische zubereitungen
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
DE69621786T2 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ATE232541T1 (de) Gallensauersälze mit physiologisch aktiven metalle und ihre verwendung zur therapeutischen behandlung
ATE175971T1 (de) Wasserlösliche retinoide
EP0811385A3 (fr) Conjugué d'un facteur reconnaissant spécifiquement le récepteur interleukin-2, avec la ribonucléase